Neutra Past Earnings Performance

Past criteria checks 0/6

Neutra has been growing earnings at an average annual rate of 32.7%, while the Pharmaceuticals industry saw earnings growing at 2.1% annually. Revenues have been growing at an average rate of 36.8% per year.

Key information

32.7%

Earnings growth rate

100.6%

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth rate36.8%
Return on equityn/a
Net Margin-269.2%
Last Earnings Update30 Apr 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Neutra makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:NTRR Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Apr 240000
31 Jan 240000
31 Oct 230000
31 Jul 230-100
30 Apr 230-100
31 Jan 230-100
31 Oct 220000
31 Jul 220-100
30 Apr 220-110
31 Jan 220-110
31 Oct 210-110
31 Jul 210-100
30 Apr 210-100
31 Jan 210-100
31 Oct 200-100
31 Jul 200-100
30 Apr 200-100
31 Jan 200-100
31 Oct 190-100
31 Jul 190-220
30 Apr 190-220
31 Jan 190-220
31 Oct 180-220
31 Jul 180000
30 Apr 180000
31 Jan 180-100
31 Oct 170-100
31 Jul 170-100
30 Apr 170-100
31 Jan 170-100
31 Oct 160-110
31 Jul 160-110
30 Apr 160-110
31 Jan 160-110
31 Oct 150-110
31 Jul 150-210
30 Apr 150-210
31 Jan 150-210
31 Oct 140-210
31 Jul 140-210
30 Apr 140-110

Quality Earnings: NTRR is currently unprofitable.

Growing Profit Margin: NTRR is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: NTRR is unprofitable, but has reduced losses over the past 5 years at a rate of 32.7% per year.

Accelerating Growth: Unable to compare NTRR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NTRR is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (54.6%).


Return on Equity

High ROE: NTRR's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies